Development of a multidisciplinary clinical approach for unexplained regression in Down syndrome
Am J Med Genet A
.
2022 Aug;188(8):2509-2511.
doi: 10.1002/ajmg.a.62870.
Epub 2022 Jun 11.
Authors
Coral M Stredny
1
,
Aaron J Hauptman
2
,
Sabrina Sargado
3
,
Cara Soccorso
3
,
Tamar Katz
4
,
Mark P Gorman
1
,
Nicole T Baumer
3
5
Affiliations
1
Programs in Multiple Sclerosis and Neuroimmunology, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
2
Kennedy Krieger Institute, Baltimore, Maryland, USA.
3
Down Syndrome Program, Developmental Medicine Center, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
4
Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts, USA.
5
Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
PMID:
35689568
DOI:
10.1002/ajmg.a.62870
No abstract available
Keywords:
Down syndrome; autoimmune; catatonia; mood dysregulation; regression.
MeSH terms
Catatonia*
Down Syndrome* / complications
Down Syndrome* / diagnosis
Down Syndrome* / genetics
Humans